Escitalopram and Tarka drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Escitalopram (escitalopram oxalate) and Tarka (trandolapril; verapamil hydrochloride). Common drug interactions include wound haemorrhage among females and dyspnoea among males.

The phase IV clinical study analyzes what interactions people have when they take Escitalopram and Tarka. It is created by eHealthMe based on reports of 22 people who take the same drugs from the FDA, and is updated regularly.

What is Escitalopram?

Escitalopram has active ingredients of escitalopram oxalate. It is often used in depression. eHealthMe is studying from 78,080 Escitalopram users. Check the latest studies of Escitalopram.

What is Tarka?

Tarka has active ingredients of trandolapril; verapamil hydrochloride. It is often used in high blood pressure. eHealthMe is studying from 2,409 Tarka users. Check the latest studies of Tarka.

On Jul, 15, 2026

22 people who take Escitalopram and Tarka together, and have interactions are studied.

Escitalopram and Tarka drug interactions.

What are the common drug interactions of Escitalopram and Tarka, by gender? *:

female:

Wound haemorrhage (bleeding wound)
Altered state of consciousness (altered state of mind)
Cerebral haemorrhage (bleeding within the brain)
Dysphagia (a condition in which swallowing is difficult or painful)
Gaze palsy (disorders affecting the ability to move both eyes in the same direction)
Hemiparesis (weakness on one side of the body)
Hemiplegia (paralysis of one side of the body)
Hepatocellular injury (liver injury)
Mineral metabolism disorder (disease of mineral utilization by body)
Neurological decompensation (inability of brain to maintain proper function)

male:

Dyspnoea (difficult or laboured respiration)
Functional gastrointestinal disorder (functional problem in separate organs of gastrointestinal system)
Biliary dilatation
Cholangitis (infection of the bile duct)
Glossodynia (a burning or painful sensation in the tongue)
Guillain-barre syndrome (the body's immune system attacks its peripheral nervous system)
Haematuria (presence of blood in urine)
Hepatic steatosis (fatty liver disease)
Hepatocellular injury (liver injury)
International normalised ratio increased

What are the common drug interactions of Escitalopram and Tarka, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Hepatocellular injury (liver injury)
Transaminases increased
Coma (state of unconsciousness lasting more than six hours)
Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
Hypokalaemia (low potassium)
Hyponatraemia (abnormally low level of sodium in the blood; associated with dehydration)

50-59:

Altered state of consciousness (altered state of mind)
Cerebral haemorrhage (bleeding within the brain)
Dysphagia (a condition in which swallowing is difficult or painful)
Gaze palsy (disorders affecting the ability to move both eyes in the same direction)
Hemiparesis (weakness on one side of the body)
Hemiplegia (paralysis of one side of the body)
Mineral metabolism disorder (disease of mineral utilization by body)
Neurological decompensation (inability of brain to maintain proper function)
Quadriplegia (a four limb paralysis)
Ageusia (loss of taste functions of the tongue)

60+:

Dyspnoea (difficult or laboured respiration)
Functional gastrointestinal disorder (functional problem in separate organs of gastrointestinal system)
Biliary dilatation
Cholangitis (infection of the bile duct)
Diarrhoea
Guillain-barre syndrome (the body's immune system attacks its peripheral nervous system)
Haematuria (presence of blood in urine)
Hepatic steatosis (fatty liver disease)
Hepatocellular injury (liver injury)
International normalised ratio increased

What are the existing conditions these people have? *

Pain: 9 people, 40.91%
Stroke (sudden death of a portion of the brain cells due to a lack of oxygen): 6 people, 27.27%
Hepatic Neoplasm Malignant (liver cancer): 4 people, 18.18%
Diarrhea: 4 people, 18.18%
Dermatosis (a disease of the skin, esp. one that does not cause inflammation): 4 people, 18.18%
Constipation: 4 people, 18.18%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 4 people, 18.18%
Psoriasis (immune-mediated disease that affects the skin): 3 people, 13.64%

* Approximation only. Some reports may have incomplete information.

Do you take Escitalopram and Tarka?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously